These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 6383995)

  • 21. Liver disease in hemophiliacs: etiological and biochemical data on 159 cases from our geographical area.
    Ruggiero G; Cesaro G; Mazzella C; Gaeta GB; Miraglia E; Mastrullo L; Boffa ML; Spiteri D; Schiattarella V; de Biasi R
    Hepatogastroenterology; 1985 Apr; 32(2):57-60. PubMed ID: 4007763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Existence of serum HBe antigen and expression of liver HB surface and core antigens in hepatitis type B patients.
    Tsuji T; Naito K; Inoue J; Tsuchiya M; Araki K; Shinohara T; Onoue K; Nagashima H; Tokuyama K; Okada T
    Acta Med Okayama; 1979 Apr; 33(2):121-31. PubMed ID: 157670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
    Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
    Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delta hepatitis in Malaysia.
    Sinniah M; Dimitrakakis M; Tan DS
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activity of guanase in serum and liver function tests in HBe antigen-positive chronic hepatitis].
    Nishikawa Y; Fukumoto K; Watanabe F; Yoshihara H
    Rinsho Byori; 1989 Dec; 37(12):1392-4. PubMed ID: 2614968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Delta hepatitis in Switzerland. Determination of delta antigens and delta antibodies in 397 HBsAg-positive patients (1978-1984)].
    Burkhardt F; Schilt U
    Schweiz Med Wochenschr; 1984 Jul; 114(30):1042-6. PubMed ID: 6474132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of HDV infection on the course of HBsAg-positive chronic hepatitis in a pediatric case series].
    Calzia R; Ciravegna B; Marazzi MG; Navone C; Piscopo R; Facco F
    Minerva Pediatr; 1986 Jun; 38(11-12):451-6. PubMed ID: 3526109
    [No Abstract]   [Full Text] [Related]  

  • 30. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt.
    el Zayadi A; Ponzetto A; Selim O; Forzani B; Lavarini C; Rizzetto M
    Hepatogastroenterology; 1988 Dec; 35(6):313-5. PubMed ID: 3265126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBe-Antigen in the course and prognosis of hepatitis B infection: a prospective study.
    Schulman AN; Fagen ND; Brezina M; Silver H; Nitzze A; Morton D; Gitnick GL
    Gastroenterology; 1980 Feb; 78(2):253-8. PubMed ID: 7350048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Occurrence of HBV serological markers in patients with chronic hepatitis].
    Cichoz-Lach H; Słomka M; Daniluk J; Celiński K; Pokora J
    Pol Arch Med Wewn; 1992 Oct; 88(4):244-9. PubMed ID: 1488325
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil].
    Paz MO; Galizzi Filho J; Simonetti JP; Simonetti SR; de Santana ZM; Barbosa MM; de Carvalho DG; Toppa NH
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(6):311-6. PubMed ID: 10413947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Delta superinfection of hepatitis B in Switzerland: histology and serology of 28 patients].
    Stöcklin E; Gudat F; Spichtin HP; von Overbeck J; Krey G; Dürmüller U; Bianchi L; Stalder GA; Altorfer J; Schmid M
    Schweiz Med Wochenschr; 1984 Jul; 114(30):1047-52. PubMed ID: 6474133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 37. [Delta virus superinfection in a patient with chronic viral hepatitis B].
    Decker T; Baumgarten R; Roschlau G
    Zentralbl Allg Pathol; 1986; 132(4):283-8. PubMed ID: 3541449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 39. [The presence and significance of HBe antigens and anti-HBe antibodies in HBs antigen positive patients].
    Zivanović-Marinković V; Kaljalović R; Marinković V; Dumović B; Lazarov A; Nanusević N; Krstić L; Parabucki S
    Zb Vojnomed Akad; 1981; 23():24-6. PubMed ID: 6963836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatitis B viral markers in the liver tissue of HBs-antigen carriers].
    Mansurov KhKh; Mirodzhov GK; Tkalicheva LI
    Arkh Patol; 1984; 46(4):46-51. PubMed ID: 6375639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.